Tag Archives: Cabergoline

Recommendations For The Use And Selection Of Antipsychotics

1. Only one antipsychotic medication should be used at a time. Combinations of antipsychotics should not be tried until monotherapy with different available agents, including conventional antipsychotics, has been used for an extended period of time, for at least six weeks, at therapeutic doses (for each medication), or when single medications at therapeutic levels bring… Read More »

Common Side Effects: Monitoring and Management Recommendations

Extrapyramidal Side Effects Antipsychotic-induced EPS may occur acutely or after long-term treatment. First-generation antipsychotics, in particular high-potency neuroleptics, are more likely than second-generation antipsychotics to cause EPS when the drugs are used at usual therapeutic doses. However, as can be noted in Table Selected side effects of commonly used antipsychotic medications, considerable variation in the… Read More »

Special Considerations for Treatment of Restless Legs Syndrome

Side Effects of Dopaminergic Treatments Dopaminergic agents (dopamine agonists and levodopa) are usually considered first-line therapy in restless legs syndrome. Common side effects of dopamine agonists include nausea, dizziness, orthostatic hypotension, and headache (). A very slow dose titration will help minimize side effects. Hallucinations are another common side effects of dopaminergic therapy in Parkinson’s… Read More »

Treatment of Sleep-Related Movement Disorders

Sleep-related movement disorders represent a newly established category of sleep disorders in the new International Classification of Sleep Disorders, second edition (ICSD-2), recently published. This category includes restless legs syndrome (restless legs syndrome), periodic limb movement disorder (periodic limb movement disorder), sleep-related leg cramps, sleep-related bruxism, sleep-related rhythmic movement disorders (RMDs), sleep-related movement disorder due… Read More »

Pharmacological Treatment Of Restless Legs Syndrome

Dopaminergic Agents in the Treatment Of Restless Legs Syndrome Levodopa was the first dopaminergic agent found effective in restless legs syndrome and has since shown evidence of efficacy in controlled trials. Benes et al. found improved quality of sleep, reduced sleep latency, and better quality of life with levodopa / benserazide given in a single… Read More »